Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2) [Phase 2]

View source ↗

Summary

Phase II randomized-registry embedded study evaluating lymphoscintigraphy to guide nodal treatment for patients with oropharyngeal cancer undergoing robotic sur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Oropharyngeal Neoplasms, Robotic Surgery and/or Radiotherapy | Phase 2 | Status: ACTIVE_NOT_RECRUITING